Literature DB >> 16738044

COPD exacerbations.5: management.

R Rodríguez-Roisin1.   

Abstract

A review of the most relevant evidence based therapeutic options currently available for the management of exacerbations of COPD.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16738044      PMCID： PMC2111219          DOI： 10.1136/thx.2005.041863

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  135 in total

Review 1.  Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

Authors:  M Johnson; S Rennard
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 2.  [Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease].

Authors:  J A Barberà; G Peces-Barba; A G Agustí; J L Izquierdo; E Monsó; T Montemayor; J L Viejo
Journal:  Arch Bronconeumol       Date:  2001-06       Impact factor: 4.872

Review 3.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

4.  Exacerbations of chronic obstructive pulmonary disease.

Authors:  J Kidney; T McManus; P V Coyle
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

5.  Systemic glucocorticoids in severe exacerbations of COPD.

Authors:  A Sayiner; Z A Aytemur; M Cirit; I Unsal
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

6.  Audit of acute admissions of COPD: standards of care and management in the hospital setting.

Authors:  C M Roberts; I Ryland; D Lowe; Y Kelly; C E Bucknall; M G Pearson
Journal:  Eur Respir J       Date:  2001-03       Impact factor: 16.671

7.  Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study).

Authors:  J Garcia-Aymerich; E Barreiro; E Farrero; R M Marrades; J Morera; J M Antó
Journal:  Eur Respir J       Date:  2000-12       Impact factor: 16.671

8.  Management of acute exacerbations of COPD: a summary and appraisal of published evidence.

Authors:  D C McCrory; C Brown; S E Gelfand; P B Bach
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

Review 9.  Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

Authors:  J M Singh; V A Palda; M B Stanbrook; K R Chapman
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

10.  Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.

Authors:  P B Bach; C Brown; S E Gelfand; D C McCrory
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391
View more
  21 in total

1.  Evaluation of stat orders in a teaching hospital: a chart review.

Authors:  Fanak Fahimi; Zahra Sahraee; Shahideh Amini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Can early diagnosis and effective management combat the irresistible rise of COPD?

Authors:  Rupert Jones
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

3.  Single-Center Retrospective Evaluation of Inhaled Corticosteroid Use for Chronic Obstructive Pulmonary Disease Exacerbation Patients Receiving Systemic Corticosteroids.

Authors:  Taylor Steuber; Dane Shiltz
Journal:  Hosp Pharm       Date:  2016-11

4.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

5.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

6.  How do COPD patients respond to exacerbations?

Authors:  Jaap C A Trappenburg; David Schaap; Evelyn M Monninkhof; Jean Bourbeau; Gerdien H de Weert-van Oene; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2011-08-19       Impact factor: 3.317

7.  The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial.

Authors:  Kris Vanhaecht; Walter Sermeus; Jan Peers; Cathy Lodewijckx; Svin Deneckere; Fabrizio Leigheb; Marc Decramer; Massimiliano Panella
Journal:  Trials       Date:  2010-11-19       Impact factor: 2.279

8.  COPD exacerbations in general practice: variability in oral prednisolone courses.

Authors:  Marianne de Vries; Annette J Berendsen; Henk E P Bosveld; Huib A M Kerstjens; Thys van der Molen
Journal:  BMC Fam Pract       Date:  2012-01-12       Impact factor: 2.497

Review 9.  Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units.

Authors:  Agi Holland; Fiona Smith; Kay Penny; Gill McCrossan; Linda Veitch; Caroline Nicholson
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

10.  Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation.

Authors:  Cathy Lodewijckx; Marc Decramer; Walter Sermeus; Massimiliano Panella; Svin Deneckere; Kris Vanhaecht
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.